Erratum: A systematic review and meta-analysis on the prevalence of dupuytren disease in the general population of western countries (Plastic and Reconstructive Surgery (2014) 133 (593-603) DOI: 10.1097/01.prs.0000438455.37604.0f);A systematic review and meta-analysis on the prevalence of dupuytren disease in the general population of western countries

Plastic and Reconstructive Surgery

Volumn 133, Issue 3, 2014, Pages 593-603

  Lanting, Rosanne ^a,b   Broekstra, Dieuwke C ^b   Werker, Paul M N ^b   Van Den Heuvel, Edwin R ^b  

^a HPC BB81 ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; DUPUYTREN CONTRACTURE; EUROPE; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; PREVALENCE; REVIEW; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DUPUYTREN CONTRACTURE; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84897661608     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000344     Document Type: Erratum

References (52)

1. Burge P. Genetics of Dupuytren's disease. Hand Clin. 1999;15:63-71.
2. Hindocha S, John S, Stanley JK, Watson SJ, Bayat A. The heri-tability of Dupuytren's disease: Familial aggregation and its clinical signifcance. J Hand Surg Am. 2006;31:204-210.
3. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet. 2005;68:424-429.
4. Dolmans GH, Werker PM, Hennies HC, et al. Wnt signaling and Dupuytren's disease. N Engl J Med. 2011;365:307-317.
5. Godtfredsen NS, Lucht H, Prescott E, Sørensen TI, Grønbaek M. A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol. 2004;57:858-863.
6. Bovenzi M. Hand-arm vibration syndrome and dose-response relation for vibration induced white fnger among quarry drillers and stonecarvers. Italian Study Group on Physical Hazards in the Stone Industry. Occup Environ Med. 1994;51:603-611.
7. Savas S, Köroglu BK, Koyuncuoglu HR, Uzar E, Celik H, Tamer NM. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77:77-83.
8. Ramchurn N, Mashamba C, Leitch E, et al. Upper limb mus-culoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med. 2009;20:718-721.
9. Arafa M, Noble J, Royle SG, Trail IA, Allen J. Dupuytren's and epilepsy revisited. J Hand Surg Br. 1992;17:221-224.
10. Beighton P, Valkenburg HA. Bone and joint disorders on Tristan da Cunha. S Afr Med J. 1974;48:743-747.
11. Bergenudd H, Lindgärde F, Nilsson BE. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health. J Hand Surg Br. 1993;18:254-257.
12. Degreef I, De Smet L. A high prevalence of Dupuytren's disease in Flanders. Acta Orthop Belg. 2010;76:316-320.
13. Eadington DW, Patrick AW, Collier A, Frier BM. Limited joint mobility, Dupuytren's contracture and retinopathy in type 1 diabetes: Association with cigarette smoking. Diabet Med. 1989;6:152-157.
14. French PD, Kitchen VS, Harris JR. Prevalence of Dupuytren's contracture in patients infected with HIV. BMJ 1990;301:967.
15. Gudmundsson KG, Arngrímsson R, Sigfússon N, Björnsson A, Jónsson T. Epidemiology of Dupuytren's disease: Clinical, serological, and social assessment. The Reykjavik Study. J Clin Epidemiol. 2000;53:291-296.
16. Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br. 2004;29:423-426.
17. Critchley EM, Vakil SD, Hayward HW, Owen VM. Dupuytren's disease in epilepsy: Result of prolonged administration of anticonvulsants. J Neurol Neurosurg Psychiatry 1976;39:498-503.
18. Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (NY) 2009;4:256-269.
19. Duin van C, Garssen J. Population forecast 2010-2060: An aging population and increased life expectancy (Bevolkingstrend 2010-2060: Sterkere vergrijzing en een langere levensduur). Available at: http://www.cbs.nl/NR/rdonlyres/ 91E3EC1E-4FF2-4019-B47E-24DC24334180/0/2010bevolkingsprognose2010 2060sterkerevergrijzingart.pdf. Accessed February 24, 2012.
20. Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. JAMA 1994;272:101-104.
21. Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. J Clin Epidemiol. 2010;63:1061-1070.
22. Lanting R, van den Heuvel ER, Westerink B, Werker PM. Prevalence of Dupuytren disease in The Netherlands. Plast Reconstr Surg. 2013;132:394-403.
23. Leemis LM, Trivedi KS. A comparison of approximate interval estimators for the Bernoulli parameter. Am Stat. 1996;50:63-68.
24. Ardic F, Soyupek F, Kahraman Y, Yorgancioglu R. The musculoskeletal complications seen in type II diabetics: Predominance of hand involvement. Clin Rheumatol. 2003;22:229-233.
25. Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone Joint Surg Br. 1984;66:322-325.
26. Noble J, Arafa M, Royle SG, McGeorge G, Crank S. The association between alcohol, hepatic pathology and Dupuytren's disease. J Hand Surg Br. 1992;17:71-74.
27. Lennox IA, Murali SR, Porter R. A study of the repeatability of the diagnosis of Dupuytren's contracture and its prevalence in the grampian region. J Hand Surg Br. 1993;18:258-261.
28. Pal B, Griffths ID, Anderson J, Dick WC. Association of limited joint mobility with Dupuytren's contracture in diabetes mellitus. J Rheumatol. 1987;14:582-585.
29. Arafa M, Steingold RF, Noble J. The incidence of Dupuytren's disease in patients with rheumatoid arthritis. J Hand Surg Br. 1984;9:165-166.
30. Attali P, Ink O, Pelletier G, et al. Dupuytren's contracture, alcohol consumption, and chronic liver disease. Arch Intern Med. 1987;147:1065-1067.
31. Aydeniz A, Gursoy S, Guney E. Which musculoskeletal complications are most frequently seen in type 2 diabetes mel-litus? J Int Med Res. 2008;36:505-511.
32. Bennett B. Dupuytren's contracture in manual workers. Br J Ind Med. 1982;39:98-100.
33. Burke FD, Proud G, Lawson IJ, McGeoch KL, Miles JN. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren's disease in 97, 537 miners. J Hand Surg Eur Vol. 2007;32:400-406.
34. Carson J, Clarke C. Dupuytren's contracture in pensioners at the Royal Hospital Chelsea. J R Coll Physicians Lond. 1993;27:25-27.
35. Descatha A, Bodin J, Ha C, et al. Heavy manual work, exposure to vibration and Dupuytren's disease? Results of a surveillance program for musculoskeletal disorders. Occup Environ Med. 2012;69:296-299.
36. Finsen V, Dalen H, Nesheim J. The prevalence of Dupuytren's disease among 2 different ethnic groups in northern Norway. J Hand Surg Am. 2002;27:115-117.
37. Lucas G, Brichet A, Roquelaure Y, Leclerc A, Descatha A. Dupuytren's disease: Personal factors and occupational exposure. Am J Ind Med. 2008;51:9-15.
38. Mikkelsen OA. The prevalence of Dupuytren's disease in Norway: A study in a representative population sample of the municipality of Haugesund. Acta Chir Scand. 1972;138:695-700.
39. Rafter D, Kenny R, Gilmore M, Walsh CH. Dupuytren's contracture: A survey of a hospital population. Ir Med J. 1980;73:227-228.
40. Ravid M, Dinai Y, Sohar E. Dupuytren's disease in diabetes mellitus. Acta Diabetol Lat. 1977;14:170-174.
41. Thomas PR, Clarke D. Vibration white fnger and Dupuytren's contracture: Are they related? Occup Med (Lond.) 1992;42:155-158.
42. Zerajic D, Finsen V. Dupuytren's disease in Bosnia and Herzegovina: An epidemiological study. BMC Musculoskelet Disord. 2004;5:10.
43. Descatha A, Jauffret P, Chastang JF, Roquelaure Y, Leclerc A. Should we consider Dupuytren's contracture as work-related? A review and meta-analysis of an old debate. BMC Musculoskelet Disord. 2011;12:96.
44. Straub G. Musculoskeletal problems in rock climbing: A review (in German). Wien Med Wochenschr. 2000;150:186-190.
45. Merritt AL, Huang JI. Hand injuries in rock climbing. J Hand Surg Am. 2011;36:1859-1861.
46. Biostatistical design of medical studies. In: van Belle G, Fisher LD, Heagerty PJ, Lumley TS, eds. Biostatistics: A Methodology for the Health Sciences. 2nd ed. Hoboken: Wiley; 2004:19-20.
47. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol. 2005;5:19.
48. Herbison P, Hay-Smith J, Gillespie WJ. Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol. 2006;59:1249-1256.
49. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2001;2:463-471.
50. Soares HP, Daniels S, Kumar A, et al.; Radiation Therapy Oncology Group. Bad reporting does not mean bad methods for randomised trials: Observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ 2004;328:22-24.
51. Iselin M, Iselin F. Maladie de Dupuytren. In: Traité de chirurgie de la main. Brussels: Flammarion; 1967:676-678.
52. Tubiana R, Michon J, Thomine JM. Scheme for the assessment of deformities in Dupuytren's disease. Surg Clin North Am. 1968;48:979-984.